SEC Tracker
Get the app
PDEX · XBRL financial data

Pro-Dex financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (PDEX's year ends in late June)

In thousands of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Revenue12,58814,29315,025*14,89216,79317,41417,494*18,53018,66319,94920,405*20,560
Cost of revenue9,78610,29110,936*9,74211,72111,61614,003*13,16312,92013,81613,314*13,703
Gross profit2,8024,0024,089*5,1505,0725,7983,491*5,3675,7436,1337,091*6,857
Research and development788760836*843942947905*7687348271,017*1,210
Selling, general and administrative————1,4381,2111,242*1,4901,7502,2122,545*2,132
General and administrative1,2001,012864*1,2461,3891,0981,109*1,417————
Total operating expenses2,0251,7891,738*2,1372,3802,1582,147*2,2582,4843,0393,562*3,342
Operating income (loss)7772,2132,351*3,0132,6923,6401,344*3,1093,2593,0943,529*3,515
Interest expense139138149*152204246227*200141201270*260
Other income (expense)2230——2115——————
Income tax expense (benefit)120258343*8535461,279402*1,5427411,402668*331
Net income (loss)5006551,587*2,4662,0403,2751,197*4,6802,1873,9382,857*3,048
Earnings per share, basic USD per share0.140.19—0.760.631.000.36*1.430.671.230.90*0.95
Earnings per share, diluted USD per share0.140.19—0.750.610.980.34*1.400.661.200.85*0.92
Weighted average shares, basic thousands of shares3,5473—3,2603,2613,2613,370*3,2623,2493,2013,190*3,206
Weighted average shares, diluted thousands of shares3,6124—3,2923,3373,3373,479*3,3393,3043,2703,355*3,315

Balance sheet

CSV

Fiscal quarters (PDEX's year ends in late June)

In thousands of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Cash and cash equivalents1,2893,2192,6313,0816633419335,2736,6278,19211,759
Short-term investments5,8034,5774,2174,7384,6715,4176,74010,0388649861,1501,230
Marketable securities7631,0004,2174,7384,6715,4176,74010,0388649861,1501,230
Marketable securities, non-current1,5091,5431,5631,4751,619111148149135456154147
Accounts receivable13,16912,51613,88713,45618,46715,86116,43318,23417,88319,47321,20517,507
Inventory15,02614,24215,26916,60419,61123,43222,21321,56421,71022,35721,45821,899
Prepaid and other current assets9011,0723454121,333619410235336560——
Total current assets36,60035,95736,61138,50244,30049,94347,29550,72349,18653,71053,24853,946
Property and equipment, net5,3315,1915,0245,1836,1086,0855,153———5,3735,359
Right-of-use asset1,6751,5751,4731,3701,2651,1581,0509418307166022,048
Goodwill—————————6,5256,5256,525
Total assets51,42750,54852,47754,30860,37464,27361,19264,29862,25674,97774,50976,589
Accounts payable2,9093,4354,5134,4425,6895,9624,6143,9654,1115,2464,2625,321
Accrued liabilities2,8462,7013,3594,0195,2343,5423,4794,1274,2584,3194,3663,224
Total current liabilities9,99010,41912,89211,28517,13918,31714,62913,60212,20114,63612,98312,884
Lease liability, non-current1,4151,2991,1821,0639398136855554198386272,089
Total liabilities19,64119,61021,61023,43128,55228,99124,56022,78520,62529,77926,87627,243
Retained earnings24,70825,36326,95029,41631,45634,73135,92840,60841,63145,19847,63349,346
Total stockholders' equity31,78630,93830,86730,87731,82235,28236,63241,51341,63145,19847,63349,346
Total liabilities and equity51,42750,54852,47754,30860,37464,27361,19264,29862,25674,97774,50976,589
Common shares outstanding (cover page) thousands of shares3,5113,4193,3583,2593,2613,2613,2623,2623,2063,1933,2033,200

Cash flows

CSV

Fiscal quarters (PDEX's year ends in late June)

In thousands of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Net income (loss)5006551,587*2,4662,0403,2751,197*4,6802,1873,9382,857*3,048
Stock-based compensation197*202*17*113130*158*154*161164*186*177*135
Depreciation and amortization286*286*306*302313*310*314*311314*363*406*403
Net cash from operating activities710*4,077*1,020*1,887(4,150)*754*(173)*2,3103,572*1,633*(273)*6,490
Purchases of property and equipment633*117*—431542*180*93*9870*112*203*346
Net cash from investing activities(1,883)*(117)*(107)*(431)(542)*1,727*(992)*(98)8,868*(5,055)*198*(346)
Share repurchases—1,723*1,675*2,3111,193*0*0*——601*600*600
Proceeds from long-term debt—0*—4,9903,500*4,400*——————
Net cash from financing activities558*(2,030)*(1,501)*(1,006)1,677*1,926*(2,889)*(2,117)(5,001)*5,462*(1,726)*(2,577)

Compare with peers

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Pro Dex11,75920,5606,4903.2M— 10-QSep 30, 2026
Sensus Healthcare15,1862,290(3,133)*16.5M4.8 quarters 10-QJun 30, 2026
Spectral AI14,0003,524(4,097)*32.2M3.4 quarters 10-QJun 30, 2026
Orchestra BioMed Holdings20,47288(19,332)*60.1M5.7 quarters 10-QJun 30, 2026
Carlsmed46,244not reported(7,358)*27.3M9.5 quarters 10-QJun 30, 2026
Myomo11,21911,705(1,944)*39.6M6.9 quarters 10-QJun 30, 2026
Edap TMS21,54213,203(3,691)*37.5M6.5 quarters 10-QJun 30, 2026
InspireMD15,1491,771(10,895)*46.5M2.8 quarters 10-QJun 30, 2026
Cytosorbents4,4139,633(583)*62.8M7.6 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.